Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.1198158779111125e-66,69.99318801089919,10628.987178930605,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.0761297955964495e-64,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,6.904026565446193e-35,25.358201581027668,1994.6348900615912,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'COX11', 'UQCRFS1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5']",1.2565328349112072e-32,0,0,45
3,Mitochondrial CIV Assembly WP4922,6.670917026606377e-16,27.64614295824487,966.0558758674623,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX11', 'COX14', 'COX20']",8.094045992282403e-14,0,0,19
4,Oxidative phosphorylation WP623,2.067311001821414e-15,16.05299801079852,542.7924393470313,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'NDUFA2', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MG', 'ATP5MF', 'ATP5ME']",1.8812530116574867e-13,0,0,22
5,Nonalcoholic fatty liver disease WP4396,3.206485517787334e-15,6.470650337837838,215.94890201500695,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'MLX', 'UQCRFS1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",2.3343214569491793e-13,0,0,36
6,Mitochondrial complex I assembly model OXPHOS system WP4324,6.228640778308815e-14,15.414165666266507,468.6990466488126,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5', 'TMEM126B']",3.778708738840681e-12,0,0,20
7,Mitochondrial complex III assembly WP4921,2.610254331992125e-06,22.583124215809285,290.33006531045123,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.0001357332252635905,0,0,7
8,Cellular Proteostasis WP4918,0.0003650276014507876,25.7175,203.56783788924255,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.016608755866010835,0,0,4
9,Pyrimidine metabolism WP4022,0.0010458964836621378,3.4671669793621014,23.794753978166067,"['NT5C', 'POLE4', 'POLD4', 'POLR3GL', 'POLE3', 'NME2', 'TK1', 'POLR2I', 'POLR2K', 'NME1', 'POLR2L']",0.04230070222811313,0,0,11
10,Proteasome Degradation WP183,0.006951615825260916,3.605922208281054,17.917038309798382,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'HLA-B', 'PSMB10', 'PSMB9']",0.23183753553714606,0,0,7
11,Base Excision Repair WP4752,0.0076423377319641515,4.946567825166073,24.109827499195696,"['POLE4', 'POLD4', 'TDG', 'APEX1', 'POLE3']",0.23183753553714606,0,0,5
12,Nucleotide Excision Repair WP4753,0.007642995677048772,4.06410763751484,19.808321016366026,"['POLE4', 'POLD4', 'RFC2', 'POLE3', 'MNAT1', 'GTF2H5']",0.23183753553714606,0,0,6
13,Sleep regulation WP3591,0.009339865672834194,3.860526315789474,18.04202847542936,"['CACNA1I', 'IL18', 'CRH', 'DRD1', 'BTBD9', 'HCRTR1']",0.26151623883935743,0,0,6
14,DNA Mismatch Repair WP531,0.011540043596250917,5.711111111111111,25.48259079329601,"['POLE4', 'POLD4', 'RFC2', 'POLE3']",0.3000411335025238,0,0,4
15,Macrophage markers WP4146,0.016117899303964553,7.703370786516854,31.798165488660157,"['CD163', 'CD14', 'CD68']",0.3911276897762065,0,0,3
16,mRNA Processing WP411,0.018413006022292892,2.4669610598153353,9.85476444879979,"['LSM7', 'SNRPD1', 'CELF1', 'SNRPG', 'SNRPE', 'SNRPB2', 'SNRPF', 'SRSF9', 'LSM2']",0.4188958870071633,0,0,9
17,Microglia Pathogen Phagocytosis Pathway WP3937,0.02542190103808281,2.9679005205320994,10.898558774309633,"['NCF2', 'ARPC1B', 'NCF4', 'ITGB2', 'CYBB', 'CYBA']",0.5443277634036554,0,0,6
18,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.028528800890874798,12.826683291770573,45.6224748783902,"['ELOB', 'ELOC']",0.5637083822109198,0,0,2
19,DNA Repair Pathways Full Network WP4946,0.030616954217117246,2.2286647314949204,7.769574027003688,"['POLE4', 'POLD4', 'CENPX', 'RFC2', 'TDG', 'APEX1', 'POLE3', 'MNAT1', 'GTF2H5']",0.5637083822109198,0,0,9
20,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.030972988033567024,5.501337613697165,19.1151666703624,"['EIF2S2', 'EIF3D', 'EIF1']",0.5637083822109198,0,0,3
21,ERK Pathway in Huntington's Disease WP3853,0.04034374433383746,4.813202247191011,15.451914294729264,"['NTRK2', 'MAPK1', 'HRAS']",0.6675055880689471,0,0,3
22,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.04034374433383746,4.813202247191011,15.451914294729264,"['RRAS2', 'MAPK1', 'HRAS']",0.6675055880689471,0,0,3
23,Selenium Micronutrient Network WP15,0.04331534737146243,2.190099433336897,6.875265844122522,"['SELENOM', 'PRDX5', 'SELENOS', 'ALOX5', 'ALOX5AP', 'SELENOW', 'TXN', 'SELENOH']",0.6855124540527097,0,0,8
24,Eukaryotic Transcription Initiation WP405,0.061032139215978366,3.021176470588235,8.44828096615274,"['GTF2A2', 'POLR2I', 'MNAT1', 'POLR2K']",0.8122820157566807,0,0,4
25,Nanomaterial induced apoptosis WP2507,0.06279779223970175,3.849812734082397,10.65564782071839,"['ENDOG', 'BAX', 'CYCS']",0.8122820157566807,0,0,3
26,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.06471477598061467,6.412094763092269,17.5548132788987,"['COX8A', 'CYP2C8']",0.8122820157566807,0,0,2
27,Cytosine methylation WP3585,0.06471477598061467,6.412094763092269,17.5548132788987,"['TDG', 'IDH2']",0.8122820157566807,0,0,2
28,Dual hijack model of Vif in HIV infection WP3300,0.06471477598061467,6.412094763092269,17.5548132788987,"['ELOB', 'ELOC']",0.8122820157566807,0,0,2
29,Nanoparticle triggered regulated necrosis WP2513,0.06471477598061467,6.412094763092269,17.5548132788987,"['TRADD', 'FTL']",0.8122820157566807,0,0,2
30,Mitochondrial CII Assembly WP4920,0.072477901323285,inf,inf,['SDHAF1'],0.8793985360558579,0,0,1
31,Cytosolic DNA-sensing pathway WP4655,0.07814369065197088,2.378436007972929,6.06312324508559,"['POLR3GL', 'TRADD', 'IL18', 'POLR2K', 'POLR2L']",0.9175581741070129,0,0,5
32,Kallmann's Syndrome WP5074,0.08980295775105028,3.207553058676654,7.73064348374402,"['MAPK1', 'GNRH1', 'FRS2']",0.9963680482689806,0,0,3
33,Translation Factors WP107,0.09609949995763704,2.2139743645073584,5.185949714512973,"['EEF1B2', 'EIF1AY', 'EIF2S2', 'EIF3D', 'EIF1']",0.9963680482689806,0,0,5
34,TYROBP causal network in microglia WP3945,0.10079603526331747,1.8738759933082392,4.299901272556297,"['CD4', 'SLC7A7', 'NCF2', 'ITGB2', 'IL18', 'CYTL1', 'SLC1A5']",0.9963680482689806,0,0,7
35,Copper homeostasis WP3286,0.10298802865276588,2.4447619047619047,5.557292247208408,"['SCO2', 'COX17', 'COX11', 'ATOX1']",0.9963680482689806,0,0,4
36,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.12075720638757106,2.748796147672552,5.810881685318271,"['H2AFJ', 'H2AFZ', 'MAPK1']",0.9963680482689806,0,0,3
37,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.1345703042611811,3.6629853936587105,7.346734450215548,"['IDH2', 'IDH3B']",0.9963680482689806,0,0,2
38,Gastric Cancer Network 2 WP2363,0.13750502668186423,2.5652933832709115,5.089785274682986,"['AHCTF1', 'S100A6', 'COL9A3']",0.9963680482689806,0,0,3
39,IL-2 signaling pathway WP49,0.14107653100503528,2.138541666666667,4.188232835374917,"['RPS6', 'MAPK1', 'HRAS', 'CRKL']",0.9963680482689806,0,0,4
40,Regulation of Actin Cytoskeleton WP51,0.14213297622940987,1.530076766222862,2.9851678474088787,"['FGF17', 'CHRM3', 'TMSB4X', 'CHRM5', 'BRK1', 'RRAS2', 'MAPK1', 'CD14', 'FGF1', 'PAK4']",0.9963680482689806,0,0,10
41,MET in type 1 papillary renal cell carcinoma WP4205,0.14900844779215747,1.8874696311565928,3.5932746100687245,"['RPL11', 'MAPK1', 'HRAS', 'CRKL', 'PAK4']",0.9963680482689806,0,0,5
42,TNF-alpha signaling pathway WP231,0.1508531616876418,1.6646916678284307,3.148678315776727,"['TRADD', 'MAPK1', 'BAX', 'CYBA', 'TXN', 'BTRC', 'HRAS']",0.9963680482689806,0,0,7
43,Serotonin and anxiety WP3947,0.16046964650006793,3.204800498753117,5.863664747378618,"['POMC', 'CRH']",0.9963680482689806,0,0,2
44,"GPCRs, Class B Secretin-like WP334",0.16046964650006793,3.204800498753117,5.863664747378618,"['ADGRE1', 'ADGRL2']",0.9963680482689806,0,0,2
45,Acute viral myocarditis WP4298,0.161764855119143,1.7116123642439431,3.1178927830629104,"['CD4', 'ENDOG', 'ITGB2', 'MAPK1', 'CYCS', 'BAX']",0.9963680482689806,0,0,6
46,Type II interferon signaling (IFNG) WP619,0.1731055483624042,2.26305353602115,3.96906496314955,"['HLA-B', 'CYBB', 'PSMB9']",0.9963680482689806,0,0,3
47,Kit receptor signaling pathway WP304,0.18553093167413182,1.7339241619592058,2.9208536203706292,"['RPS6', 'GRB10', 'MAPK1', 'HRAS', 'CRKL']",0.9963680482689806,0,0,5
48,Cytokines and Inflammatory Response WP530,0.18716430111521512,2.8484344693821004,4.773316565251208,"['CD4', 'HLA-DRB1']",0.9963680482689806,0,0,2
49,Fatty acid transporters WP5061,0.18716430111521512,2.8484344693821004,4.773316565251208,"['FABP6', 'DBI']",0.9963680482689806,0,0,2
50,LTF danger signal response pathway WP4478,0.18716430111521512,2.8484344693821004,4.773316565251208,"['MAPK1', 'CD14']",0.9963680482689806,0,0,2
51,Overview of nanoparticle effects WP3287,0.18716430111521512,2.8484344693821004,4.773316565251208,"['COL4A1', 'BAX']",0.9963680482689806,0,0,2
52,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.18716430111521512,2.8484344693821004,4.773316565251208,"['CD4', 'HLA-DRB1']",0.9963680482689806,0,0,2
53,Heme Biosynthesis WP561,0.20207238848396677,6.405354919053549,10.24299064433321,['HMBS'],0.9963680482689806,0,0,1
54,Metabolism of alpha-linolenic acid WP4586,0.20207238848396677,6.405354919053549,10.24299064433321,['ALOX5'],0.9963680482689806,0,0,1
55,CAMKK2  Pathway WP4874,0.21093599950762698,2.024443130297654,3.1504394346409077,"['CHRM3', 'FIS1', 'MAPK1']",0.9963680482689806,0,0,3
56,IL-18 signaling pathway WP4754,0.22585686772561195,1.2846835443037974,1.9114213047454622,"['NRN1', 'NCF2', 'COX17', 'IL18', 'TNFRSF11B', 'NDUFC1', 'RND2', 'RASA3', 'NACA', 'TMSB4X', 'CYCS', 'MAPK1', 'BAX', 'RPS11']",0.9963680482689806,0,0,14
57,BDNF-TrkB Signaling WP3676,0.23047849962934908,1.9230337078651685,2.8222398428241573,"['NTRK2', 'MAPK1', 'HRAS']",0.9963680482689806,0,0,3
58,MAPK Cascade WP422,0.23047849962934908,1.9230337078651685,2.8222398428241573,"['RASA3', 'MAPK1', 'HRAS']",0.9963680482689806,0,0,3
59,Signaling of Hepatocyte Growth Factor Receptor WP313,0.25033346901665204,1.8312823256643482,2.5362552857063183,"['MAPK1', 'HRAS', 'CRKL']",0.9963680482689806,0,0,3
60,p38 MAPK Signaling Pathway WP400,0.25033346901665204,1.8312823256643482,2.5362552857063183,"['TRADD', 'DDIT3', 'HRAS']",0.9963680482689806,0,0,3
61,MED and Pseudoachondroplasia genes WP4789,0.2599202648329042,4.269821502698215,5.753073670675001,['COL9A3'],0.9963680482689806,0,0,1
62,Mevalonate pathway WP3963,0.2599202648329042,4.269821502698215,5.753073670675001,['PMVK'],0.9963680482689806,0,0,1
63,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.26966824220773034,2.1357024106400666,2.7989721484658063,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
64,Type II diabetes mellitus WP1584,0.26966824220773034,2.1357024106400666,2.7989721484658063,"['SURF1', 'MAPK1']",0.9963680482689806,0,0,2
65,Eicosanoid Synthesis WP167,0.26966824220773034,2.1357024106400666,2.7989721484658063,"['ALOX5', 'ALOX5AP']",0.9963680482689806,0,0,2
66,Splicing factor NOVA regulated synaptic proteins WP4148,0.2704260290094531,1.7478719782090568,2.285791252345164,"['KCNQ2', 'GRIK2', 'ANK3']",0.9963680482689806,0,0,3
67,Bladder cancer WP2828,0.2704260290094531,1.7478719782090568,2.285791252345164,"['DAPK1', 'MAPK1', 'HRAS']",0.9963680482689806,0,0,3
68,Modulators of TCR signaling and T cell activation WP5072,0.295554105774506,1.5080882352941176,1.838213816918392,"['NDUFB10', 'RHOH', 'ELOB', 'RNF7']",0.9963680482689806,0,0,4
69,TP53 network WP1742,0.29733982346237803,1.971225781699597,2.3908595524414933,"['SUMO1', 'BAX']",0.9963680482689806,0,0,2
70,NRF2 pathway WP2884,0.3055650874117783,1.282537688442211,1.5205670271632272,"['SERPINA1', 'SLC6A9', 'FTH1', 'ME1', 'TXN', 'SLC6A20', 'SLC5A3', 'FTL']",0.9963680482689806,0,0,8
71,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.31357914064087233,3.202054794520548,3.713434179716244,['MAPK1'],0.9963680482689806,0,0,1
72,Benzo(a)pyrene metabolism WP696,0.31357914064087233,3.202054794520548,3.713434179716244,['AKR1A1'],0.9963680482689806,0,0,1
73,"Cerebral organic acidurias, including diseases WP4519",0.31357914064087233,3.202054794520548,3.713434179716244,['IDH2'],0.9963680482689806,0,0,1
74,Valproic acid pathway WP3871,0.31357914064087233,3.202054794520548,3.713434179716244,['HSD17B10'],0.9963680482689806,0,0,1
75,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.31357914064087233,3.202054794520548,3.713434179716244,['PMVK'],0.9963680482689806,0,0,1
76,Peroxiredoxin 2 induced ovarian failure WP4873,0.31357914064087233,3.202054794520548,3.713434179716244,['BAX'],0.9963680482689806,0,0,1
77,Ebstein-Barr virus LMP1 signaling WP262,0.32484154912853,1.8302458140363378,2.057960892395745,"['TRADD', 'MAPK1']",0.9963680482689806,0,0,2
78,PPAR signaling pathway WP3942,0.32913282643631336,1.4240277777777777,1.582513357132769,"['FABP6', 'ME1', 'DBI', 'CPT1B']",0.9963680482689806,0,0,4
79,Interleukin-11 Signaling Pathway WP2332,0.33144027019080513,1.5376779026217229,1.6980694957202014,"['RPS6', 'MAPK1', 'HRAS']",0.9963680482689806,0,0,3
80,Monoamine GPCRs WP58,0.33144027019080513,1.5376779026217229,1.6980694957202014,"['CHRM3', 'CHRM5', 'DRD1']",0.9963680482689806,0,0,3
81,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.3518152557267293,1.4783923941227313,1.5444012586084033,"['NTRK2', 'MAPK1', 'HRAS']",0.9963680482689806,0,0,3
82,Ferroptosis WP4313,0.3518152557267293,1.4783923941227313,1.5444012586084033,"['FTH1', 'CYBB', 'FTL']",0.9963680482689806,0,0,3
83,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.35205279018206725,1.7080631753948463,1.783173788903825,"['RPS6', 'MAPK1']",0.9963680482689806,0,0,2
84,IL1 and megakaryocytes in obesity WP2865,0.35205279018206725,1.7080631753948463,1.783173788903825,"['TLR1', 'IL18']",0.9963680482689806,0,0,2
85,Serotonin and anxiety-related events WP3944,0.3633520063879323,2.5613947696139476,2.5931130333747623,['CRH'],0.9963680482689806,0,0,1
86,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.3633520063879323,2.5613947696139476,2.5931130333747623,['VEGFB'],0.9963680482689806,0,0,1
87,Type 2 papillary renal cell carcinoma WP4241,0.3788712543899905,1.6011533665835411,1.5540135377850828,"['ELOB', 'ELOC']",0.9963680482689806,0,0,2
88,Nanoparticle-mediated activation of receptor signaling WP2643,0.3788712543899905,1.6011533665835411,1.5540135377850828,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
89,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.3788712543899905,1.6011533665835411,1.5540135377850828,"['GRB10', 'HRAS']",0.9963680482689806,0,0,2
90,"Relationship between inflammation, COX-2 and EGFR WP4483",0.3788712543899905,1.6011533665835411,1.5540135377850828,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
91,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.3797789589107309,1.314102564102564,1.272269268780641,"['APEX1', 'RPS6', 'MAPK1', 'HRAS']",0.9963680482689806,0,0,4
92,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.39229026239711184,1.3725254146602461,1.2843451145964944,"['NDUFA13', 'COPS6', 'IL18']",0.9963680482689806,0,0,3
93,Disruption of postsynaptic signaling by CNV WP4875,0.40521096744189816,1.506821182338272,1.3611830579597821,"['MAPK1', 'DLGAP1']",0.9963680482689806,0,0,2
94,Glycosylation and related congenital defects WP4521,0.40521096744189816,1.506821182338272,1.3611830579597821,"['DPM2', 'DPM3']",0.9963680482689806,0,0,2
95,Parkinson's disease pathway WP2371,0.40521096744189816,1.506821182338272,1.3611830579597821,"['CYCS', 'PARK7']",0.9963680482689806,0,0,2
96,TCA cycle in senescence WP5050,0.4095199634734535,2.134288086342881,1.9054275766768767,['ME1'],0.9963680482689806,0,0,1
97,Bile acids synthesis and enterohepatic circulation  WP4389,0.4095199634734535,2.134288086342881,1.9054275766768767,['MAPK1'],0.9963680482689806,0,0,1
98,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.4095199634734535,2.134288086342881,1.9054275766768767,['SST'],0.9963680482689806,0,0,1
99,Codeine and Morphine Metabolism WP1604,0.4095199634734535,2.134288086342881,1.9054275766768767,['CYP2C8'],0.9963680482689806,0,0,1
100,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.4095199634734535,2.134288086342881,1.9054275766768767,['CYP2C8'],0.9963680482689806,0,0,1
101,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4095199634734535,2.134288086342881,1.9054275766768767,['RPS6'],0.9963680482689806,0,0,1
102,Insulin signaling in adipocytes (normal condition) WP3634,0.4095199634734535,2.134288086342881,1.9054275766768767,['RPS6'],0.9963680482689806,0,0,1
103,Purine metabolism WP4792,0.4095199634734535,2.134288086342881,1.9054275766768767,['APRT'],0.9963680482689806,0,0,1
104,Ciliary landscape WP4352,0.4107221745931766,1.124110654469928,1.0002766770105096,"['COPS6', 'IFT22', 'PSMD7', 'NDUFA5', 'SSNA1', 'MYL6B', 'TMED1', 'SNRPB2', 'COX6C', 'LSM4']",0.9963680482689806,0,0,10
105,p53 transcriptional gene network WP4963,0.41229513363038156,1.325067803177063,1.1740310657647304,"['SIVA1', 'NCF2', 'BAX']",0.9963680482689806,0,0,3
106,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4270310880974027,1.186089092847541,1.0092413855572409,"['POMC', 'RPS6', 'MAPK1', 'FRS2', 'HRAS']",0.9963680482689806,0,0,5
107,GABA receptor Signaling WP4159,0.43100044961693085,1.4229703518980328,1.1976375120978666,"['SLC32A1', 'GABRA4']",0.9963680482689806,0,0,2
108,VEGFA-VEGFR2 Signaling Pathway WP3888,0.43727008364055636,1.0559881988946043,0.8735179096310156,"['NCF2', 'RPS6', 'IDH2', 'CYBB', 'FRS2', 'TXN', 'RPL10A', 'RPL7', 'CYP2C8', 'RPL18A', 'TMSB4X', 'GRB10', 'RPLP2', 'CYCS', 'MAPK1', 'RPL27', 'RPL26', 'ELOC', 'RPS11', 'TMSB10', 'EIF3D', 'HRAS']",0.9963680482689806,0,0,22
109,Endometrial cancer WP4155,0.44652537335787407,1.1913953488372093,0.9605732857627445,"['MAPK1', 'BAX', 'FGF1', 'HRAS']",0.9963680482689806,0,0,4
110,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.45234380305206334,1.8292118840064047,1.4511371320905255,['DLL3'],0.9963680482689806,0,0,1
111,Biomarkers for pyrimidine metabolism disorders WP4584,0.45234380305206334,1.8292118840064047,1.4511371320905255,['NT5C'],0.9963680482689806,0,0,1
112,Cancer immunotherapy by CTLA4 blockade WP4582,0.45234380305206334,1.8292118840064047,1.4511371320905255,['HLA-DRB1'],0.9963680482689806,0,0,1
113,Homologous recombination WP186,0.45234380305206334,1.8292118840064047,1.4511371320905255,['POLD4'],0.9963680482689806,0,0,1
114,Iron metabolism in placenta WP2007,0.45234380305206334,1.8292118840064047,1.4511371320905255,['FTH1'],0.9963680482689806,0,0,1
115,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.45234380305206334,1.8292118840064047,1.4511371320905255,['BAX'],0.9963680482689806,0,0,1
116,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.45234380305206334,1.8292118840064047,1.4511371320905255,['MAPK1'],0.9963680482689806,0,0,1
117,Osteoclast Signaling WP12,0.45234380305206334,1.8292118840064047,1.4511371320905255,['TNFRSF11B'],0.9963680482689806,0,0,1
118,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.45606465694757387,1.1435052744502057,0.8977896477708399,"['RPS6', 'RRAS2', 'MAPK1', 'BAX', 'HRAS']",0.9963680482689806,0,0,5
119,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.4561810707346649,1.3479459246620291,1.0579562027180351,"['TNFRSF11B', 'PPIB']",0.9963680482689806,0,0,2
120,Fluoropyrimidine Activity WP1601,0.4561810707346649,1.3479459246620291,1.0579562027180351,"['TDG', 'TK1']",0.9963680482689806,0,0,2
121,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.4561810707346649,1.3479459246620291,1.0579562027180351,"['NTRK2', 'GABRA4']",0.9963680482689806,0,0,2
122,Alzheimer's disease WP2059,0.46289352060435784,1.1642045454545455,0.8967381307249058,"['ATP5MD', 'MAPK1', 'CYCS', 'HSD17B10']",0.9963680482689806,0,0,4
123,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.4807055669188826,1.280423940149626,0.9379109501083178,"['MAPK1', 'BAX']",0.9963680482689806,0,0,2
124,Tamoxifen metabolism WP691,0.4920654719243671,1.6004047322540473,1.1349166105685224,['CYP2C8'],0.9963680482689806,0,0,1
125,IL-9 signaling pathway WP22,0.4920654719243671,1.6004047322540473,1.1349166105685224,['MAPK1'],0.9963680482689806,0,0,1
126,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.4920654719243671,1.6004047322540473,1.1349166105685224,['MAPK1'],0.9963680482689806,0,0,1
127,Osteoblast Signaling WP322,0.4920654719243671,1.6004047322540473,1.1349166105685224,['TNFRSF11B'],0.9963680482689806,0,0,1
128,Osteopontin Signaling WP1434,0.4920654719243671,1.6004047322540473,1.1349166105685224,['MAPK1'],0.9963680482689806,0,0,1
129,Pyrimidine metabolism and related diseases WP4225,0.4920654719243671,1.6004047322540473,1.1349166105685224,['NT5C'],0.9963680482689806,0,0,1
130,RalA downstream regulated genes WP2290,0.4920654719243671,1.6004047322540473,1.1349166105685224,['HRAS'],0.9963680482689806,0,0,1
131,22q11.2 copy number variation syndrome WP4657,0.49878282337343727,1.0850427441081012,0.7547389164494213,"['RANBP1', 'P2RX6', 'MRPL40', 'CRKL', 'PAK4']",0.9963680482689806,0,0,5
132,Endothelin Pathways WP2197,0.5045367042946849,1.2193326208288802,0.8341633555028828,"['RIIAD1', 'MAPK1']",0.9963680482689806,0,0,2
133,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.5045367042946849,1.2193326208288802,0.8341633555028828,"['DDIT3', 'MAPK1']",0.9963680482689806,0,0,2
134,IL-3 signaling pathway WP286,0.5084541882289905,1.129654108834545,0.764075626347721,"['MAPK1', 'HRAS', 'CRKL']",0.9963680482689806,0,0,3
135,Non-small cell lung cancer WP4255,0.5108790938313394,1.0895744680851063,0.7317825361626636,"['MAPK1', 'CYCS', 'BAX', 'HRAS']",0.9963680482689806,0,0,4
136,Vitamin D Receptor Pathway WP2877,0.5169485231091261,1.0344652555707832,0.6825525663317571,"['LRRC25', 'COLEC11', 'CRACR2A', 'ALOX5', 'S100A6', 'TNFRSF11B', 'CD14', 'HLA-DRB1']",0.9963680482689806,0,0,8
137,Leptin signaling pathway WP2034,0.5264399717002185,1.0667708333333332,0.684459334162751,"['RPS6', 'MAPK1', 'BAX', 'HRAS']",0.9963680482689806,0,0,4
138,7q11.23 copy number variation syndrome WP4932,0.5265374636703583,1.0492623976692177,0.6730313112402504,"['RFC2', 'ATP5MC2', 'ATP5PO', 'ATP5F1E', 'ATP5MC1']",0.9963680482689806,0,0,5
139,PDGF Pathway WP2526,0.5276460767166645,1.1637950578100205,0.7440485464907536,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
140,Genes targeted by miRNAs in adipocytes WP1992,0.5289094321479098,1.422443614224436,0.9060084868440385,['TMSB4X'],0.9963680482689806,0,0,1
141,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.5289094321479098,1.422443614224436,0.9060084868440385,['MAPK1'],0.9963680482689806,0,0,1
142,Complement system WP2806,0.5401595531544452,1.0322378779926522,0.6357457239647726,"['FCGR3A', 'RPS19', 'ITGB2', 'VSIG4', 'TXN']",0.9963680482689806,0,0,5
143,Integrin-mediated Cell Adhesion WP185,0.5401595531544452,1.0322378779926522,0.6357457239647726,"['ITGB2', 'MAPK1', 'ITGAE', 'HRAS', 'PAK4']",0.9963680482689806,0,0,5
144,T-cell receptor (TCR) signaling pathway WP69,0.5417570278455566,1.0448979591836736,0.6404573164789276,"['CD4', 'MAPK1', 'HRAS', 'CRKL']",0.9963680482689806,0,0,4
145,Heart Development WP1591,0.5500130239683695,1.1130868480971485,0.6654181453264479,"['VEGFB', 'MAPK1']",0.9963680482689806,0,0,2
146,Apoptosis Modulation and Signaling WP1772,0.5535967363975621,1.0157538192581996,0.6006342989571563,"['ENDOG', 'TRADD', 'CYCS', 'BAX', 'TNFRSF11B']",0.9963680482689806,0,0,5
147,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.5612303462149786,0.9953018262930433,0.5749100811944512,"['NTRK2', 'NCF2', 'RPS6', 'MAPK1', 'FRS2', 'EIF2S2', 'HRAS']",0.9963680482689806,0,0,7
148,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5630839235400168,1.2800747198007472,0.735180957791841,['CD4'],0.9963680482689806,0,0,1
149,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.5630839235400168,1.2800747198007472,0.735180957791841,['MAPK1'],0.9963680482689806,0,0,1
150,Cholesterol Biosynthesis Pathway WP197,0.5630839235400168,1.2800747198007472,0.735180957791841,['PMVK'],0.9963680482689806,0,0,1
151,Farnesoid X receptor pathway WP2879,0.5630839235400168,1.2800747198007472,0.735180957791841,['SLCO2B1'],0.9963680482689806,0,0,1
152,Galanin receptor pathway WP4970,0.5630839235400168,1.2800747198007472,0.735180957791841,['POMC'],0.9963680482689806,0,0,1
153,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5630839235400168,1.2800747198007472,0.735180957791841,['RPS6'],0.9963680482689806,0,0,1
154,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5630839235400168,1.2800747198007472,0.735180957791841,['BAX'],0.9963680482689806,0,0,1
155,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5630839235400168,1.2800747198007472,0.735180957791841,['MAPK1'],0.9963680482689806,0,0,1
156,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5630839235400168,1.2800747198007472,0.735180957791841,['GPC6'],0.9963680482689806,0,0,1
157,Nucleotide metabolism WP404,0.5630839235400168,1.2800747198007472,0.735180957791841,['NME2'],0.9963680482689806,0,0,1
158,Purine metabolism and related disorders WP4224,0.5630839235400168,1.2800747198007472,0.735180957791841,['APRT'],0.9963680482689806,0,0,1
159,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5630839235400168,1.2800747198007472,0.735180957791841,['ANAPC11'],0.9963680482689806,0,0,1
160,Alpha 6 Beta 4 signaling pathway WP244,0.5716236611418174,1.0666043225270159,0.5965245343331661,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
161,Toll-like Receptor Signaling related to MyD88 WP3858,0.5716236611418174,1.0666043225270159,0.5965245343331661,"['TLR1', 'MAPK1']",0.9963680482689806,0,0,2
162,Common Pathways Underlying Drug Addiction WP2636,0.5716236611418174,1.0666043225270159,0.5965245343331661,"['MAPK1', 'DRD1']",0.9963680482689806,0,0,2
163,Hippo-Merlin Signaling Dysregulation WP4541,0.5755141939599464,0.9842876421823791,0.5438104450529586,"['NTRK2', 'ITGB2', 'ITGAE', 'HRAS', 'CDH8', 'PAK4']",0.9963680482689806,0,0,6
164,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.5924700067652031,1.0238403990024938,0.535934405492692,"['ITGB2', 'CD14']",0.9963680482689806,0,0,2
165,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5924700067652031,1.0238403990024938,0.535934405492692,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
166,Small Ligand GPCRs WP247,0.5947821343124454,1.163591078908638,0.6045554988402164,['PTAFR'],0.9963680482689806,0,0,1
167,Apoptosis Modulation by HSP70 WP384,0.5947821343124454,1.163591078908638,0.6045554988402164,['CYCS'],0.9963680482689806,0,0,1
168,Transcriptional cascade regulating adipogenesis WP4211,0.5947821343124454,1.163591078908638,0.6045554988402164,['DDIT3'],0.9963680482689806,0,0,1
169,Cells and molecules involved in local acute inflammatory response  WP4493,0.5947821343124454,1.163591078908638,0.6045554988402164,['ITGB2'],0.9963680482689806,0,0,1
170,Hypertrophy Model WP516,0.5947821343124454,1.163591078908638,0.6045554988402164,['IL18'],0.9963680482689806,0,0,1
171,Methionine De Novo and Salvage Pathway WP3580,0.5947821343124454,1.163591078908638,0.6045554988402164,['TXN'],0.9963680482689806,0,0,1
172,MTHFR deficiency WP4288,0.5947821343124454,1.163591078908638,0.6045554988402164,['CYCS'],0.9963680482689806,0,0,1
173,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5947821343124454,1.163591078908638,0.6045554988402164,['SCO2'],0.9963680482689806,0,0,1
174,NOTCH1 regulation of endothelial cell calcification WP3413,0.5947821343124454,1.163591078908638,0.6045554988402164,['DLL3'],0.9963680482689806,0,0,1
175,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5957218144107681,0.9843464899644675,0.5098732470042004,"['IFI27L2', 'MAPK1', 'HRAS']",0.9963680482689806,0,0,3
176,Oncostatin M Signaling Pathway WP2374,0.5957218144107681,0.9843464899644675,0.5098732470042004,"['RPS6', 'MAPK1', 'HRAS']",0.9963680482689806,0,0,3
177,Corticotropin-releasing hormone signaling pathway WP2355,0.6003351525778703,0.9656603773584905,0.4927448092655528,"['POMC', 'IL18', 'CRH', 'MAPK1']",0.9963680482689806,0,0,4
178,Prolactin Signaling Pathway WP2037,0.6003351525778703,0.9656603773584905,0.4927448092655528,"['RPS6', 'MAPK1', 'PPIB', 'HRAS']",0.9963680482689806,0,0,4
179,Allograft Rejection WP2328,0.6119175167872835,0.9596441947565543,0.471336714248361,"['HLA-B', 'HLA-DOA', 'HLA-DRB1']",0.9963680482689806,0,0,3
180,Prader-Willi and Angelman Syndrome WP3998,0.6119175167872835,0.9596441947565543,0.471336714248361,"['POMC', 'FEZ1', 'GNRH1']",0.9963680482689806,0,0,3
181,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6125492020556245,0.9843660080567811,0.48246338381281145,"['ARHGDIB', 'CYCS']",0.9963680482689806,0,0,2
182,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.624183288101307,1.0665213781652139,0.5026634948977727,['MAPK1'],0.9963680482689806,0,0,1
183,Development and heterogeneity of the ILC family WP3893,0.624183288101307,1.0665213781652139,0.5026634948977727,['IL18'],0.9963680482689806,0,0,1
184,Intraflagellar transport proteins binding to dynein WP4532,0.624183288101307,1.0665213781652139,0.5026634948977727,['IFT22'],0.9963680482689806,0,0,1
185,PPAR-alpha pathway WP2878,0.624183288101307,1.0665213781652139,0.5026634948977727,['DBI'],0.9963680482689806,0,0,1
186,Wnt Signaling Pathway WP363,0.6318628119964605,0.9478156460700101,0.43512602941570816,"['RYK', 'MAPK1']",0.9963680482689806,0,0,2
187,DNA Replication WP466,0.6318628119964605,0.9478156460700101,0.43512602941570816,"['POLD4', 'RFC2']",0.9963680482689806,0,0,2
188,Circadian rhythm related genes WP3594,0.6486391218668385,0.9132268485283561,0.3953165144891465,"['KDM5A', 'CAVIN3', 'CRH', 'DRD1', 'BTRC', 'RPS27A', 'BTBD9', 'HCRTR1']",0.9963680482689806,0,0,8
189,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6504162004928115,0.9138760242251515,0.39309720338401455,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
190,IL-5 signaling pathway WP127,0.6504162004928115,0.9138760242251515,0.39309720338401455,"['RPS6', 'MAPK1']",0.9963680482689806,0,0,2
191,Metabolic reprogramming in colon cancer WP4290,0.6504162004928115,0.9138760242251515,0.39309720338401455,"['IDH2', 'SLC1A5']",0.9963680482689806,0,0,2
192,Signal Transduction of S1P Receptor WP26,0.6514536518754953,0.9843854775361625,0.4218574371972453,['MAPK1'],0.9963680482689806,0,0,1
193,Sphingolipid Metabolism (general overview) WP4725,0.6514536518754953,0.9843854775361625,0.4218574371972453,['CERS6'],0.9963680482689806,0,0,1
194,Sphingolipid Metabolism (integrated pathway) WP4726,0.6514536518754953,0.9843854775361625,0.4218574371972453,['CERS6'],0.9963680482689806,0,0,1
195,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.6514536518754953,0.9843854775361625,0.4218574371972453,['CD63'],0.9963680482689806,0,0,1
196,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6514536518754953,0.9843854775361625,0.4218574371972453,['BAX'],0.9963680482689806,0,0,1
197,Physiological and pathological hypertrophy of the heart WP1528,0.6514536518754953,0.9843854775361625,0.4218574371972453,['MAPK1'],0.9963680482689806,0,0,1
198,Thermogenesis WP4321,0.6541690261765977,0.8975438596491228,0.38090819979270685,"['RPS6', 'FRS2', 'CPT1B', 'HRAS']",0.9963680482689806,0,0,4
199,ErbB signaling pathway WP673,0.6541690261765977,0.8975438596491228,0.38090819979270685,"['MAPK1', 'HRAS', 'CRKL', 'PAK4']",0.9963680482689806,0,0,4
200,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6578388210505125,0.8924309729117673,0.3737459242253091,"['MAPK1', 'BAX', 'HRAS']",0.9963680482689806,0,0,3
201,Aryl Hydrocarbon Receptor Netpath WP2586,0.6682179727723815,0.8822770659558001,0.35568192818101224,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
202,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6682179727723815,0.8822770659558001,0.35568192818101224,"['ITGB2', 'PAK4']",0.9963680482689806,0,0,2
203,Neural Crest Cell Migration in Cancer WP4565,0.6682179727723815,0.8822770659558001,0.35568192818101224,"['NTRK2', 'PAK4']",0.9963680482689806,0,0,2
204,Nuclear Receptors Meta-Pathway WP2882,0.6713280748531284,0.9076012241542489,0.36167666207286325,"['SERPINA1', 'DBI', 'TXN', 'SLC6A20', 'SLC5A3', 'PSMC5', 'SLC6A9', 'FTH1', 'SLCO2B1', 'ALOX5AP', 'ME1', 'BAX', 'FTL']",0.9963680482689806,0,0,13
205,Melanoma WP4685,0.672246543058146,0.8720633299284984,0.3463226202619388,"['MAPK1', 'BAX', 'HRAS']",0.9963680482689806,0,0,3
206,Statin inhibition of cholesterol production WP430,0.6767474718529882,0.9139832769969757,0.35687124718318264,['APOC1'],0.9963680482689806,0,0,1
207,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.6767474718529882,0.9139832769969757,0.35687124718318264,['MAPK1'],0.9963680482689806,0,0,1
208,Cancer immunotherapy by PD-1 blockade WP4585,0.6767474718529882,0.9139832769969757,0.35687124718318264,['HLA-DRB1'],0.9963680482689806,0,0,1
209,Proteoglycan biosynthesis WP4784,0.6767474718529882,0.9139832769969757,0.35687124718318264,['EXT2'],0.9963680482689806,0,0,1
210,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6852794784505721,0.8527847049044056,0.32229166668214815,"['PPP1R14B', 'DDIT3']",0.9963680482689806,0,0,2
211,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6997108921151678,0.8339846930467351,0.29780595985991376,"['MAPK1', 'CYCS', 'BAX']",0.9963680482689806,0,0,3
212,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.700207841295382,0.8529680365296803,0.3039791042280403,['TLR1'],0.9963680482689806,0,0,1
213,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.700207841295382,0.8529680365296803,0.3039791042280403,['MAPK1'],0.9963680482689806,0,0,1
214,miRNA targets in ECM and membrane receptors WP2911,0.700207841295382,0.8529680365296803,0.3039791042280403,['COL4A1'],0.9963680482689806,0,0,1
215,Purinergic signaling WP4900,0.700207841295382,0.8529680365296803,0.3039791042280403,['P2RX6'],0.9963680482689806,0,0,1
216,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.700207841295382,0.8529680365296803,0.3039791042280403,['BAX'],0.9963680482689806,0,0,1
217,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7016143695191726,0.8251950768240689,0.2924254992160512,"['RPS6', 'MAPK1']",0.9963680482689806,0,0,2
218,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7172382077966651,0.7993298004987531,0.2656550731174301,"['RPS6', 'MAPK1']",0.9963680482689806,0,0,2
219,Genotoxicity pathway WP4286,0.7172382077966651,0.7993298004987531,0.2656550731174301,"['RPS27', 'TRIAP1']",0.9963680482689806,0,0,2
220,EPO Receptor Signaling WP581,0.7219675062662985,0.799579701120797,0.26048319408987364,['MAPK1'],0.9963680482689806,0,0,1
221,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7219675062662985,0.799579701120797,0.26048319408987364,['MAPK1'],0.9963680482689806,0,0,1
222,IL-7 signaling pathway WP205,0.7219675062662985,0.799579701120797,0.26048319408987364,['MAPK1'],0.9963680482689806,0,0,1
223,RAS and bradykinin pathways in COVID-19 WP4969,0.7219675062662985,0.799579701120797,0.26048319408987364,['MAPK1'],0.9963680482689806,0,0,1
224,Hematopoietic Stem Cell Differentiation WP2849,0.73216811714054,0.775032116678002,0.2416124826711983,"['RHOH', 'ACVR1B']",0.9963680482689806,0,0,2
225,Breast cancer pathway WP4262,0.7322198686498139,0.8243188616703048,0.2569191221594765,"['FGF17', 'MAPK1', 'BAX', 'FGF1', 'HRAS', 'DLL3']",0.9963680482689806,0,0,6
226,Cannabinoid receptor signaling WP3869,0.7421496125614279,0.7524723463482529,0.22439058108394694,['MAPK1'],0.9963680482689806,0,0,1
227,Estrogen signaling pathway WP712,0.7421496125614279,0.7524723463482529,0.22439058108394694,['MAPK1'],0.9963680482689806,0,0,1
228,Interferon type I signaling pathways WP585,0.746422475843125,0.7521637083761186,0.21998044394194485,"['RPS6', 'CRKL']",0.9963680482689806,0,0,2
229,Lung fibrosis WP3624,0.746422475843125,0.7521637083761186,0.21998044394194485,"['SERPINA1', 'FGF1']",0.9963680482689806,0,0,2
230,Pathogenic Escherichia coli infection WP2272,0.746422475843125,0.7521637083761186,0.21998044394194485,"['ARPC1B', 'CD14']",0.9963680482689806,0,0,2
231,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7600206453086393,0.7306020662629141,0.20048428008064123,"['MAPK1', 'RNF7']",0.9963680482689806,0,0,2
232,Angiogenesis WP1539,0.7608683998197302,0.7105991421059914,0.19420309779508088,['MAPK1'],0.9963680482689806,0,0,1
233,Unfolded protein response WP4925,0.7608683998197302,0.7105991421059914,0.19420309779508088,['DDIT3'],0.9963680482689806,0,0,1
234,Fatty acid beta-oxidation WP143,0.7608683998197302,0.7105991421059914,0.19420309779508088,['CPT1B'],0.9963680482689806,0,0,1
235,Imatinib and Chronic Myeloid Leukemia WP3640,0.7608683998197302,0.7105991421059914,0.19420309779508088,['SKP2'],0.9963680482689806,0,0,1
236,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.7608683998197302,0.7105991421059914,0.19420309779508088,['FTL'],0.9963680482689806,0,0,1
237,Oxidative Stress WP408,0.7608683998197302,0.7105991421059914,0.19420309779508088,['CYBB'],0.9963680482689806,0,0,1
238,PDGFR-beta pathway WP3972,0.7608683998197302,0.7105991421059914,0.19420309779508088,['HRAS'],0.9963680482689806,0,0,1
239,Photodynamic therapy-induced unfolded protein response WP3613,0.7608683998197302,0.7105991421059914,0.19420309779508088,['DDIT3'],0.9963680482689806,0,0,1
240,Pregnane X receptor pathway WP2876,0.7608683998197302,0.7105991421059914,0.19420309779508088,['PSMC5'],0.9963680482689806,0,0,1
241,Resistin as a regulator of inflammation WP4481,0.7608683998197302,0.7105991421059914,0.19420309779508088,['MAPK1'],0.9963680482689806,0,0,1
242,ESC Pluripotency Pathways WP3931,0.7663923573399798,0.7628358208955224,0.20296088005623156,"['FGF17', 'MAPK1', 'FGF1', 'HRAS']",0.9963680482689806,0,0,4
243,Apoptosis WP254,0.7715491436594558,0.7373235378853357,0.19122848007597693,"['TRADD', 'CYCS', 'BAX']",0.9963680482689806,0,0,3
244,MAPK Signaling Pathway WP382,0.7721832807350352,0.8180746625331008,0.21149958048292128,"['FGF17', 'CACNA1I', 'NTRK2', 'DDIT3', 'RRAS2', 'MAPK1', 'CD14', 'FGF1', 'HRAS', 'CRKL']",0.9963680482689806,0,0,10
245,Synaptic Vesicle Pathway WP2267,0.7729827316994922,0.7102382931559988,0.1828853448271622,"['SLC32A1', 'PARK7']",0.9963680482689806,0,0,2
246,Netrin-UNC5B signaling pathway WP4747,0.7729827316994922,0.7102382931559988,0.1828853448271622,"['DAPK1', 'MAPK1']",0.9963680482689806,0,0,2
247,RANKL/RANK signaling pathway WP2018,0.7729827316994922,0.7102382931559988,0.1828853448271622,"['MAPK1', 'TNFRSF11B']",0.9963680482689806,0,0,2
248,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.7782298442651601,0.6731336435734417,0.16877706609754517,['ALOX5'],0.9963680482689806,0,0,1
249,SARS-CoV-2 mitochondrial interactions WP5038,0.7782298442651601,0.6731336435734417,0.16877706609754517,['NDUFB9'],0.9963680482689806,0,0,1
250,Ras signaling WP4223,0.7901837706263212,0.7770225301401996,0.18298083322946135,"['NTRK2', 'RASA3', 'RRAS2', 'MAPK1', 'RASAL2', 'HRAS', 'PAK4']",0.9963680482689806,0,0,7
251,Sphingolipid pathway WP1422,0.7943322561580581,0.6394146948941469,0.1472274373233588,['CERS6'],0.9963680482689806,0,0,1
252,Canonical and non-canonical Notch signaling WP3845,0.7943322561580581,0.6394146948941469,0.1472274373233588,['DLL3'],0.9963680482689806,0,0,1
253,Cell migration and invasion through p75NTR WP4561,0.7943322561580581,0.6394146948941469,0.1472274373233588,['NTRK2'],0.9963680482689806,0,0,1
254,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7943322561580581,0.6394146948941469,0.1472274373233588,['SUPT4H1'],0.9963680482689806,0,0,1
255,Monoamine Transport WP727,0.7943322561580581,0.6394146948941469,0.1472274373233588,['TNFRSF11B'],0.9963680482689806,0,0,1
256,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7970815725777375,0.6727260795379971,0.15257310153521222,"['PSMC5', 'PSMD7']",0.9963680482689806,0,0,2
257,Proximal tubule transport WP4917,0.7970815725777375,0.6727260795379971,0.15257310153521222,"['SLC7A7', 'SLC6A20']",0.9963680482689806,0,0,2
258,Toll-like Receptor Signaling Pathway WP75,0.8018430961430002,0.6969016002723868,0.1539053738645119,"['TLR1', 'MAPK1', 'CD14']",0.9963680482689806,0,0,3
259,Ebola Virus Pathway on Host WP4217,0.8024779482002867,0.7195774647887324,0.1583436710733512,"['HLA-B', 'MAPK1', 'HLA-DOA', 'HLA-DRB1']",0.9963680482689806,0,0,4
260,Metapathway biotransformation Phase I and II WP702,0.806087965843395,0.7338195733172213,0.1581839110822941,"['GSTK1', 'CYP2C8', 'GSTO1', 'AKR1A1', 'HS6ST3']",0.9963680482689806,0,0,5
261,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8082605075522021,0.6554127501758424,0.13951827715287543,"['TMSB4X', 'MAPK1']",0.9963680482689806,0,0,2
262,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8092668334598627,0.6089070746604993,0.12886092484294126,['HRAS'],0.9963680482689806,0,0,1
263,miRNA regulation of prostate cancer signaling pathways WP3981,0.8092668334598627,0.6089070746604993,0.12886092484294126,['MAPK1'],0.9963680482689806,0,0,1
264,Prion disease pathway WP3995,0.8092668334598627,0.6089070746604993,0.12886092484294126,['MAPK1'],0.9963680482689806,0,0,1
265,Androgen receptor signaling pathway WP138,0.820109442661708,0.6723174978645114,0.13333231258793887,"['SUMO1', 'BAG1', 'PARK7']",0.9963680482689806,0,0,3
266,Amyotrophic lateral sclerosis (ALS) WP2447,0.8231181758496156,0.5811728744480924,0.1131284947526277,['BAX'],0.9963680482689806,0,0,1
267,Vitamin D-sensitive calcium signaling in depression WP4698,0.8231181758496156,0.5811728744480924,0.1131284947526277,['KCNQ2'],0.9963680482689806,0,0,1
268,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8231181758496156,0.5811728744480924,0.1131284947526277,['BAX'],0.9963680482689806,0,0,1
269,White fat cell differentiation WP4149,0.835964761749766,0.555850343819373,0.0995910489774197,['DDIT3'],0.9963680482689806,0,0,1
270,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.835964761749766,0.555850343819373,0.0995910489774197,['FGF1'],0.9963680482689806,0,0,1
271,EGF/EGFR signaling pathway WP437,0.8370426279545435,0.7154802895088188,0.1272698344710483,"['NDUFA13', 'GRB10', 'MAPK1', 'NEDD8', 'HRAS', 'CRKL']",0.9963680482689806,0,0,6
272,DNA damage response WP707,0.8385697403360916,0.6084194276214226,0.10711682068504917,"['CYCS', 'BAX']",0.9963680482689806,0,0,2
273,MECP2 and Associated Rett Syndrome WP3584,0.8385697403360916,0.6084194276214226,0.10711682068504917,"['SST', 'RPS6']",0.9963680482689806,0,0,2
274,miRNA regulation of DNA damage response WP1530,0.847666911537301,0.5942121440584585,0.09820396345214724,"['CYCS', 'BAX']",0.9963680482689806,0,0,2
275,Aryl Hydrocarbon Receptor Pathway WP2873,0.8589295922513993,0.5112826899128269,0.0777499023282108,['BAX'],0.9963680482689806,0,0,1
276,G13 Signaling Pathway WP524,0.8589295922513993,0.5112826899128269,0.0777499023282108,['ARHGDIB'],0.9963680482689806,0,0,1
277,IL17 signaling pathway WP2112,0.8589295922513993,0.5112826899128269,0.0777499023282108,['MAPK1'],0.9963680482689806,0,0,1
278,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8589295922513993,0.5112826899128269,0.0777499023282108,['CYCS'],0.9963680482689806,0,0,1
279,Rett syndrome causing genes WP4312,0.8589295922513993,0.5112826899128269,0.0777499023282108,['GPS2'],0.9963680482689806,0,0,1
280,Spinal Cord Injury WP2431,0.8672195805766986,0.6380625,0.09090034226584737,"['COL4A1', 'APEX1', 'TNFSF13', 'MAPK1']",0.9963680482689806,0,0,4
281,TGF-beta Signaling Pathway WP366,0.8672195805766986,0.6380625,0.09090034226584737,"['PARD6A', 'SUMO1', 'MAPK1', 'BTRC']",0.9963680482689806,0,0,4
282,Tryptophan metabolism WP465,0.8691780106856182,0.4915700737618546,0.06892172718467424,['HSD17B10'],0.9963680482689806,0,0,1
283,IL-6 signaling pathway WP364,0.8691780106856182,0.4915700737618546,0.06892172718467424,['MAPK1'],0.9963680482689806,0,0,1
284,Notch Signaling WP268,0.8691780106856182,0.4915700737618546,0.06892172718467424,['DLL3'],0.9963680482689806,0,0,1
285,B Cell Receptor Signaling Pathway WP23,0.8731287587806428,0.5983731273408239,0.08118262493917348,"['MAPK1', 'HRAS', 'CRKL']",0.9963680482689806,0,0,3
286,Pancreatic adenocarcinoma pathway WP4263,0.8731287587806428,0.5983731273408239,0.08118262493917348,"['MAPK1', 'BAX', 'PAK4']",0.9963680482689806,0,0,3
287,"GPCRs, Class A Rhodopsin-like WP455",0.8763270915122052,0.6863526686613262,0.09060944166158207,"['CHRM3', 'GPR65', 'PTAFR', 'CHRM5', 'OR6A2', 'DRD1', 'HCRTR1']",0.9963680482689806,0,0,7
288,Integrated Cancer Pathway WP1971,0.8786827542287466,0.47331765139984316,0.06121481705088251,['BAX'],0.9963680482689806,0,0,1
289,Oxidative Damage WP3941,0.8786827542287466,0.47331765139984316,0.06121481705088251,['CYCS'],0.9963680482689806,0,0,1
290,Regulation of Microtubule Cytoskeleton WP2038,0.8786827542287466,0.47331765139984316,0.06121481705088251,['PARD6A'],0.9963680482689806,0,0,1
291,AGE/RAGE pathway WP2324,0.8795673715133602,0.5434286623865867,0.06973554596268672,"['MAPK1', 'CYCS']",0.9963680482689806,0,0,2
292,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8858730988917133,0.7218119889237009,0.0874703085303357,"['FGF17', 'CSF3R', 'CAB39L', 'COL4A1', 'RPS6', 'ITGB2', 'VEGFB', 'MAPK1', 'ITGAE', 'FGF1', 'HRAS']",0.9963680482689806,0,0,11
293,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8874977250706342,0.4563689734922612,0.05446732708280963,['MAPK1'],0.9963680482689806,0,0,1
294,Differentiation Pathway WP2848,0.8874977250706342,0.4563689734922612,0.05446732708280963,['FGF1'],0.9963680482689806,0,0,1
295,Neovascularisation processes WP4331,0.8874977250706342,0.4563689734922612,0.05446732708280963,['MAPK1'],0.9963680482689806,0,0,1
296,Neural Crest Cell Migration during Development WP4564,0.8874977250706342,0.4563689734922612,0.05446732708280963,['PAK4'],0.9963680482689806,0,0,1
297,Oxidation by Cytochrome P450 WP43,0.8874977250706342,0.4563689734922612,0.05446732708280963,['CYP2C8'],0.9963680482689806,0,0,1
298,Small cell lung cancer WP4658,0.8912675833732929,0.5714125999217397,0.06577563497240993,"['COL4A1', 'CYCS', 'BAX']",0.9963680482689806,0,0,3
299,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8930937629539453,0.5211461143060716,0.05892271100337715,"['CSF3R', 'MAPK1']",0.9963680482689806,0,0,2
300,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8956729231076337,0.4405891699231331,0.048544103209916825,['BAX'],0.9963680482689806,0,0,1
301,Exercise-induced Circadian Regulation WP410,0.8956729231076337,0.4405891699231331,0.048544103209916825,['SUMO1'],0.9963680482689806,0,0,1
302,Pre-implantation embryo WP3527,0.8956729231076337,0.4405891699231331,0.048544103209916825,['DDIT3'],0.9963680482689806,0,0,1
303,Vitamin A and carotenoid metabolism WP716,0.9032547279468318,0.4258613532586135,0.04333167997831412,['MAPK1'],0.9963680482689806,0,0,1
304,Myometrial relaxation and contraction pathways WP289,0.9042453220582883,0.6128453836526427,0.06168569558323956,"['RGS19', 'GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9963680482689806,0,0,5
305,Integrated breast cancer pathway WP1984,0.9085716685095984,0.5796022727272727,0.055573139729316295,"['TRADD', 'MAPK1', 'BAX', 'FAU']",0.9963680482689806,0,0,4
306,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9102861609201379,0.41208371831438556,0.038734330947082764,['PMVK'],0.9963680482689806,0,0,1
307,Head and Neck Squamous Cell Carcinoma WP4674,0.9107565455697837,0.4909361212353731,0.045892539784481795,"['RPS6', 'HRAS']",0.9963680482689806,0,0,2
308,DNA damage response (only ATM dependent) WP710,0.9118284056362319,0.5390093369203988,0.04975242586733546,"['MAPK1', 'BAX', 'HRAS']",0.9963680482689806,0,0,3
309,"GPCRs, Other WP117",0.9160096359546251,0.4816261233708182,0.04225228667887197,"['CHRM3', 'ADGRL2']",0.9963680482689806,0,0,2
310,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9168071278680936,0.39916718555417185,0.034670926601668324,['BAX'],0.9963680482689806,0,0,1
311,Prostaglandin Synthesis and Regulation WP98,0.9168071278680936,0.39916718555417185,0.034670926601668324,['S100A6'],0.9963680482689806,0,0,1
312,Gastrin signaling pathway WP4659,0.9207254297513977,0.5241393463649889,0.043290455433977276,"['RPS6', 'MAPK1', 'HRAS']",0.9963680482689806,0,0,3
313,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9228546445493463,0.3870334729612438,0.031072416692106225,['DBI'],0.9963680482689806,0,0,1
314,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9228546445493463,0.3870334729612438,0.031072416692106225,['TRADD'],0.9963680482689806,0,0,1
315,Hepatitis B infection WP4666,0.924608296650773,0.5541847826086956,0.04343982640881086,"['CYCS', 'MAPK1', 'BAX', 'HRAS']",0.9963680482689806,0,0,4
316,Retinoblastoma gene in cancer WP2446,0.9256559978485488,0.46402176377238724,0.035846890473845455,"['H2AFZ', 'SKP2']",0.9963680482689806,0,0,2
317,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9284630456638748,0.3756135081678998,0.027879799591731178,['CD4'],0.9963680482689806,0,0,1
318,Phosphodiesterases in neuronal function WP4222,0.9284630456638748,0.3756135081678998,0.027879799591731178,['DRD1'],0.9963680482689806,0,0,1
319,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9284630456638748,0.3756135081678998,0.027879799591731178,['TRADD'],0.9963680482689806,0,0,1
320,Osteoblast differentiation WP4787,0.9287949791207812,0.5100624219725344,0.037676910675111704,"['MAPK1', 'FGF1', 'DLL3']",0.9963680482689806,0,0,3
321,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9316382288601935,0.5422872340425532,0.03839974195789587,"['COL4A1', 'MAPK1', 'HRAS', 'DLL3']",0.9963680482689806,0,0,4
322,TGF-beta Receptor Signaling WP560,0.9336641788550665,0.3648461127913183,0.025042474207839206,['HRAS'],0.9963680482689806,0,0,1
323,Glioblastoma signaling pathways WP2261,0.9342503041590046,0.44765279782998646,0.030445262976287225,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
324,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9384875846086886,0.35467690604676905,0.022516894635481094,['MAPK1'],0.9963680482689806,0,0,1
325,Cardiac Hypertrophic Response WP2795,0.9384875846086886,0.35467690604676905,0.022516894635481094,['MAPK1'],0.9963680482689806,0,0,1
326,IL-4 signaling pathway WP395,0.9384875846086886,0.35467690604676905,0.022516894635481094,['MAPK1'],0.9963680482689806,0,0,1
327,Regulation of toll-like receptor signaling pathway WP1449,0.9427143383953369,0.4840468401839473,0.02855487704827537,"['TLR1', 'MAPK1', 'CD14']",0.9963680482689806,0,0,3
328,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9429606633096956,0.3450573861532766,0.020265465842150936,['HRAS'],0.9963680482689806,0,0,1
329,IL-1 signaling pathway WP195,0.9429606633096956,0.3450573861532766,0.020265465842150936,['MAPK1'],0.9963680482689806,0,0,1
330,Focal Adhesion WP306,0.9459142002638374,0.5698013690943777,0.03168289996428123,"['COL4A1', 'VEGFB', 'MAPK1', 'HRAS', 'CRKL', 'PAK4']",0.9963680482689806,0,0,6
331,Notch Signaling Pathway Netpath WP61,0.9471088298462159,0.3359441567804942,0.018255632719385108,['DLL3'],0.9963680482689806,0,0,1
332,Pathways in clear cell renal cell carcinoma WP4018,0.9486949254357064,0.4181349903928703,0.02202233432792235,"['ME1', 'GRB10']",0.9963680482689806,0,0,2
333,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.950955657649921,0.32729827250375193,0.016459124665735472,['TNFRSF11B'],0.9963680482689806,0,0,1
334,Calcium Regulation in the Cardiac Cell WP536,0.9518128577054648,0.5043564356435644,0.02490857137449705,"['CHRM3', 'RGS19', 'CHRM5', 'RGS6']",0.9963680482689806,0,0,4
335,Glucocorticoid Receptor Pathway WP2880,0.9545230116642972,0.3190846824408468,0.014851326692358453,['ALOX5AP'],0.9963680482689806,0,0,1
336,Senescence and Autophagy in Cancer WP615,0.9547296549772915,0.40478169655227014,0.018752346902654028,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
337,Pathways Regulating Hippo Signaling WP4540,0.9600820371692792,0.39225014387109153,0.01597891476889108,"['NTRK2', 'CDH8']",0.9963680482689806,0,0,2
338,AMP-activated protein kinase (AMPK) signaling WP1403,0.9608989500019613,0.303830872324023,0.012118606201651439,['CPT1B'],0.9963680482689806,0,0,1
339,Complement and Coagulation Cascades WP558,0.9608989500019613,0.303830872324023,0.012118606201651439,['SERPINA1'],0.9963680482689806,0,0,1
340,Peptide GPCRs WP24,0.9608989500019613,0.303830872324023,0.012118606201651439,['HCRTR1'],0.9963680482689806,0,0,1
341,PI3K-Akt signaling pathway WP4172,0.9637871498708375,0.6015495362135447,0.022188038929425065,"['FGF17', 'NTRK2', 'CSF3R', 'COL4A1', 'RPS6', 'VEGFB', 'MAPK1', 'COL9A3', 'FGF1', 'HRAS']",0.9963680482689806,0,0,10
342,Pathways affected in adenoid cystic carcinoma WP3651,0.9663818788635745,0.28996377221781955,0.009915660061866175,['HRAS'],0.9963680482689806,0,0,1
343,Fragile X Syndrome  WP4549,0.9669880875151867,0.3748349713950418,0.012582873619177478,"['NTRK2', 'MAPK1']",0.9963680482689806,0,0,2
344,Chemokine signaling pathway WP3929,0.9707614013575366,0.4197225994978804,0.012455085788927575,"['MAPK1', 'HRAS', 'CRKL']",0.9963680482689806,0,0,3
345,16p11.2 proximal deletion syndrome WP4949,0.971096738080527,0.27730250690345987,0.008133057463739607,['TMEM219'],0.9963680482689806,0,0,1
346,Endochondral Ossification with Skeletal Dysplasias WP4808,0.971096738080527,0.27730250690345987,0.008133057463739607,['CTSV'],0.9963680482689806,0,0,1
347,Endochondral Ossification WP474,0.971096738080527,0.27730250690345987,0.008133057463739607,['CTSV'],0.9963680482689806,0,0,1
348,G1 to S cell cycle control WP45,0.971096738080527,0.27730250690345987,0.008133057463739607,['MNAT1'],0.9963680482689806,0,0,1
349,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9751510060997477,0.2656963470319635,0.00668570175021832,['MAPK1'],0.9963680482689806,0,0,1
350,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9769598378636446,0.2602485577045264,0.0060663250172085445,['RYK'],0.9963680482689806,0,0,1
351,Cell cycle WP179,0.9775133539707996,0.3442407494776572,0.007829179541289224,"['SKP2', 'ANAPC11']",0.9963680482689806,0,0,2
352,Mesodermal commitment pathway WP2857,0.9793161024490037,0.3935287076721109,0.008225067007349875,"['EXT2', 'RPL38', 'AHDC1']",0.9963680482689806,0,0,3
353,Insulin Signaling WP481,0.9804867182527442,0.38947489108002753,0.007675062048013174,"['GRB10', 'MAPK1', 'HRAS']",0.9963680482689806,0,0,3
354,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9816346614978456,0.24516237187470064,0.004544348108444353,['RYK'],0.9963680482689806,0,0,1
355,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9826386415783362,0.3264594922949038,0.0057175574121688605,"['MAPK1', 'HRAS']",0.9963680482689806,0,0,2
356,Endoderm differentiation WP2853,0.9857187837127735,0.31427603829931344,0.004520601305554783,"['AHDC1', 'NME1']",0.9963680482689806,0,0,2
357,Adipogenesis WP236,0.9890104965848086,0.2993692239988265,0.003308129939742096,"['CELF1', 'DDIT3']",0.9963680482689806,0,0,2
358,G Protein Signaling Pathways WP35,0.9891830998400676,0.21592755978639425,0.0023483910342164305,['HRAS'],0.9963680482689806,0,0,1
359,Neural Crest Differentiation WP2064,0.9925900255649648,0.19896092777085927,0.0014797847681758737,['DLL3'],0.9963680482689806,0,0,1
360,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9926051524227673,0.27946616974048394,0.002074288740365597,"['NTRK2', 'SST']",0.9963680482689806,0,0,2
361,Ectoderm Differentiation WP2858,0.9926051524227673,0.27946616974048394,0.002074288740365597,"['TNFRSF11B', 'CDH8']",0.9963680482689806,0,0,2
362,Wnt signaling WP428,0.9936307734110988,0.19289407147439527,0.001232515313477482,['RYK'],0.9963680482689806,0,0,1
363,Male infertility WP4673,0.9936307734110988,0.19289407147439527,0.001232515313477482,['PEX10'],0.9963680482689806,0,0,1
364,Ciliopathies WP4803,0.9998642000269816,0.10826920415961512,1.470395342443498e-05,['CCDC28B'],0.9998642000269816,0,0,1
